• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

Geneia Partners with Covidien to Enter $21B Remote Patient Monitoring Market

by Jasmine Pennic 09/04/2014 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

geneia

Geneia today announced a multi-year, strategic partnership with Covidien to help improve the health of and reduce the costs for chronically ill patients.  The partnership  with Covidien has agreed to provide Geneia with rights to sell its ZephyrLIFE remote patient monitoring solutions in designated markets to monitor patients with heart disease, diabetes, and other chronic illnesses in the home setting.  

Geneia’s @home product combines Covidien’s ZephyrLIFE remote monitoring technology with Geneia’s clinical care expertise to better manage chronic and acute conditions.  Patients use the @home remote monitoring device to record their vital signs on a daily basis, including weight, pulse, blood pressure, blood oxygen level, and blood glucose.  Geneia merges this patient data with administrative and clinical data sets to provide an early warning about patients at risk and trigger the deployment of early intervention strategies such as telephonic support and home visits by clinicians.  As a result, @home is able to: 

  • Reduce hospital admissions/readmissions, observation bed days, and emergency department visits,
  • Ensure appropriate medication usage,
  • Improve adherence to recommended preventive care, 
  • Improve coordination of care between the patient and their physician(s); and 
  • Enable and engage patients and the people in their support system to participate in managing their health and well-being.

Geneia also announced that Capital BlueCross, a $3 billion health plan with over 700,000 members, is the first of the Blue plans to pilot @home to monitor patients with congestive heart failure.  “At Capital BlueCross, our members afflicted with congestive heart failure are among the sickest and costliest members we have. We’re confident that @home will improve the health outcomes and reduce hospital readmissions for these members,” said Dr. Jennifer Chambers, Senior Vice President and Chief Medical Officer of Capital BlueCross. 

This service is now available to other Blue plans and insurance carriers across the country as a value-add service to chronically ill patients.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Interview

Reach7 Diabetes Studios Founder Chun Yong on Reimagining Chronic Care with a Concierge Medical Model

Most-Read

Bayer Exits Radiology AI Market, Discontinuing Calantic and Blackford

Bayer Exits Radiology AI Market, Discontinuing Calantic and Blackford

Oracle Health Launches AI Center of Excellence for Healthcare

Oracle Health Launches AI Center of Excellence for Healthcare

Particle Health Addresses Integration to Epic Data Despite Dispute

US Court Allows Particle’s Antitrust Claims Against Epic to Proceed

Epic Launches Comet: A New AI Platform to Predict Patient Health Journeys

Epic Launches Comet: A New AI Platform to Predict Patient Health Journeys

Preparing for the ‘Big Beautiful Bill’: How Digitization Can Streamline Medicaid Eligibility & Social Care Delivery

Preparing for the ‘Big Beautiful Bill’: How Digitization Can Streamline Medicaid Eligibility & Social Care Delivery

Evernorth Health Services Invests $3.5B in Shields Health Solutions

Evernorth Health Services Invests $3.5B in Shields Health Solutions

KLAS Report: Oracle Health Faces Customer Losses and Declining Satisfaction

KLAS Report: Oracle Health Faces Customer Losses and Declining Satisfaction

Tempus AI Acquires Digital Pathology Leader Paige for $81.25M

M&A:Tempus AI Acquires Digital Pathology Leader Paige for $81.25M

Mira Launches Ultra4™, the First At-Home Hormone Monitor with Lab-Quality Insights

Femtech: Mira Launches Ultra4™, the First At-Home Hormone Monitor with Lab-Quality Insights

How Healthcare CIOs Can Solve the Unstructured Data Crisis and Reduce Storage Costs

How Healthcare CIOs Can Solve the Unstructured Data Crisis and Reduce Storage Costs

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |